Stocks and InvestingStocks and Investing
Mon, July 18, 2022
Sat, July 16, 2022
Fri, July 15, 2022

Thomas Shrader Initiated (ABOS) at Strong Buy and Held Target at $15 on, Jul 15th, 2022


Published on 2024-10-27 21:56:48 - WOPRAI, Thomas Shrader
  Print publication without navigation


Thomas Shrader of BTIG, Initiated "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy and Held Target at $15 on, Jul 15th, 2022.

Thomas has made no other calls on ABOS in the last 4 months.



There are 2 other peers that have a rating on ABOS. Out of the 2 peers that are also analyzing ABOS, 0 agree with Thomas's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Thomas


  • Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $15 on, Thursday, June 30th, 2022
  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $17 on, Tuesday, March 29th, 2022